MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Prevalence of sleep disorders in Parkinson’s disease patients at a Brazilian movement disorders center in 2022

    L. Castanheira, C. Lobo, I. Oliveira, L. de Almeida, G. Valença (Salvador, Brazil)

    Objective: To describe the prevalence of the main sleep disorders in patients with Parkinson's disease at a referral outpatient clinic for movement disorders. Background: Parkinson's…
  • 2022 International Congress

    Effect of lower limb vs. abdominal compression on mobility in orthostatic hypotension – a single-blinded, randomized, controlled, cross-over study in Parkinson’s disease

    S. Paschen, C. Hansen, J. Welzel, J. Albrecht, A. Atresaei, K. Aminian, KE. Zeuner, R. Romijnders, E. Warmerdam, PP. Urban, D. Berg, W. Maetzler (Kiel, Germany)

    Objective: Orthostatic hypotension (OH) in Parkinson’s disease (PD) is frequent and associated with reduced quality of life and reduced activities of daily living. Abdominal binders…
  • 2022 International Congress

    Novel strategies based on sensory electrical stimulation to manage tremor in Parkinson’s disease. A pilot study.

    C. Montero Pardo, M. González Sánchez, A. Pascual Valdunciel, J. Sánchez Pérez, J. Camilo Moreno, F. Oliveira Barroso, F. Grandas, J. Luis Pons (Madrid, Spain)

    Objective: Tremor can be a disabling motor symptom in patients with Parkinson´s disease (PD) and in some patients is refractory to medication. Here we present…
  • 2022 International Congress

    Focused Ultrasound Subthalamotomy in Parkinson’s Disease: Lesion Topography and Motor Improvement.

    J. Mañez-Miro, R. Rodríguez-Rojas, J. Pineda-Pardo, M. Del álamo, R. Martinez-Fernandez, J. Obeso (MOSTOLES, Spain)

    Objective: To describe the topography of unilateral focused ultrasound (FUS) subthalamotomy in Parkinson’s disease (PD), and define correlations between lesion size/location and improvement of cardinal…
  • 2022 International Congress

    Balance evaluation in Parkinson’s disease using a set of simple tests

    K. Krzysztoń, J. Stolarski, A. Poznańska, J. Kochanowski (Warsaw, Poland)

    Objective: The study aimed to evaluate balance using a proposed set of tests in people with Parkinson’s disease compared to healthy people. Background: Numerous balance…
  • 2022 International Congress

    The effect of co-administration of opicapone on the pharmacokinetics of levodopa

    D. Kamiyama, N. Nishikawa, G. Oyama, T. Hatano, N. Hattori (Tokyo, Japan)

    Objective: Few studies have examined levodopa (LD) pharmacokinetics in combination with opicapone (OPC) in Japanese patients with Parkinson's disease (PD). Therefore, we investigated changes in…
  • 2022 International Congress

    DNMT1 level and global DNA methylation in CD45+ blood cells in Parkinson’s disease

    A. Lavrinova, A. Zhuravlev, I. Miliukhina, E. Belykh, A. Tyurin, O. Berkovich, S. Pchelina, A. Emelyanov (Gatchina, Russian Federation)

    Objective: The aim of our study was to assess the alterations in DNA methyltransferase1 (DNMT1) level and global DNA methylation (5-mC) in CD45+ blood cells…
  • 2022 International Congress

    Movement disorder practice in a rural setting: challenges and opportunities and utility of telemedicine

    P. Karau, R. Mbijiwe (Meru, Kenya)

    Objective: To describe the experience of a movement disorder practice in a rural setting, the role of telehealth and the conditions diagnosed and managed Background:…
  • 2022 International Congress

    Safinamide adherence: the experience of the movement disorder unit of Trieste.

    M. Catalan, M. Liccari, V. Tommasini, L. Antonutti, P. Manganotti (Trieste, Italy)

    Objective: Describe the clinical experience with Safinamide and assess the patients’ adherence to this treatment in the movement disorders centre of Trieste-Italy. Background: Safinamide (Xadago®)…
  • 2022 International Congress

    Hidden effects of COVID-19 pandemic on Parkinson’s Disease: a telemedicine survey

    V. Tommasini, C. Bertolotti, M. Catalan, P. Polverino, L. Antonutti, G. Bellavita, A. Cucca, M. Liccari, P. Manganotti (Trieste, Italy)

    Objective: The aim of this study was to report the telemedicine experience of our Movement Disorder Unit during COVID-19 pandemic and to assess the clinical…
  • « Previous Page
  • 1
  • …
  • 341
  • 342
  • 343
  • 344
  • 345
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley